LIPOSOMAL DOXORUBICIN AND VINORELBINE COMBINATION IN ADVANCED HEAVILY PRETREATED EPITHELIAL OVARIAN CANCER: A PHASE II AND PHARMACOCINETIC STUDY | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

ABSTRACTS: POSTERS: Ovary

LIPOSOMAL DOXORUBICIN AND VINORELBINE COMBINATION IN ADVANCED HEAVILY PRETREATED EPITHELIAL OVARIAN CANCER: A PHASE II AND PHARMACOCINETIC STUDY

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Katsaros D, Oletti MV, de la Longrais IAR, et al

LIPOSOMAL DOXORUBICIN AND VINORELBINE COMBINATION IN ADVANCED HEAVILY PRETREATED EPITHELIAL OVARIAN CANCER: A PHASE II AND PHARMACOCINETIC STUDY

International Journal of Gynecologic Cancer 2003;13:45-46.